Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Retinal effects of 6 months of daily use of tadalafil or sildenafil.

Cordell WH, Maturi RK, Costigan TM, Marmor MF, Weleber RG, Coupland SG, Danis RP, McGettigan JW Jr, Antoszyk AN, Klise S, Sides GD; ERG Testing During Chronic PDE5 Inhibitor Administration (ERG-PDE5i) Consortium.

Arch Ophthalmol. 2009 Apr;127(4):367-73. doi: 10.1001/archophthalmol.2009.36.

PMID:
19365010
2.

Tadalafil relieves lower urinary tract symptoms secondary to benign prostatic hyperplasia.

McVary KT, Roehrborn CG, Kaminetsky JC, Auerbach SM, Wachs B, Young JM, Esler A, Sides GD, Denes BS.

J Urol. 2007 Apr;177(4):1401-7.

PMID:
17382741
3.

Efficacy of tadalafil in men with erectile dysfunction naïve to phosphodiesterase 5 inhibitor therapy compared with prior responders to sildenafil citrate.

Broderick GA, Donatucci CF, Hatzichristou D, Torres LO, Valiquette L, Zhao Y, Loughney K, Sides GD, Ahuja S.

J Sex Med. 2006 Jul;3(4):668-675. doi: 10.1111/j.1743-6109.2006.00273.x.

PMID:
16839323
4.

Semen and sperm reference ranges for men 45 years of age and older.

Hellstrom WJ, Overstreet JW, Sikka SC, Denne J, Ahuja S, Hoover AM, Sides GD, Cordell WH, Harrison LM, Whitaker JS.

J Androl. 2006 May-Jun;27(3):421-8. Epub 2006 Feb 1.

6.

Impact of a soluble phospholipase A2 inhibitor on inhaled allergen challenge in subjects with asthma.

Bowton DL, Dmitrienko AA, Israel E, Zeiher BG, Sides GD.

J Asthma. 2005 Feb;42(1):65-71.

PMID:
15801331
7.

A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis.

Bradley JD, Dmitrienko AA, Kivitz AJ, Gluck OS, Weaver AL, Wiesenhutter C, Myers SL, Sides GD.

J Rheumatol. 2005 Mar;32(3):417-23.

PMID:
15742431
9.

Comparative efficacy of 5 days of dirithromycin and 7 days of erythromycin in skin and soft tissue infections.

Wasilewski MM, Wilson MG, Sides GD, Stotka JL.

J Antimicrob Chemother. 2000 Aug;46(2):255-62.

PMID:
10933649
10.
11.

Comparison of dirithromycin and penicillin for treatment of streptococcal pharyngitis.

Watkins VS, Smietana M, Conforti PM, Sides GD, Huck W.

Antimicrob Agents Chemother. 1997 Jan;41(1):72-5.

12.

Clinical efficacy of dirithromycin in patients with bacteremic pneumonia.

Hernández JM, Sides GD, Conforti PM, Smietana MG.

Clin Ther. 1996 Nov-Dec;18(6):1128-38.

PMID:
9001829
13.

Tonsillar tissue penetration of dirithromycin after multiple doses.

Benson JM, Arnold J, Manning SC, Coleman DL, Sides GD, Conforti PM, Lemon E, Watkins VS.

J Clin Pharmacol. 1996 Sep;36(9):832-7.

PMID:
8889904
14.

The Influence of Dirithromycin on the Pharmacokinetics of Cyclosporine in Healthy Subjects and in Renal Transplant Patients.

Bachmann K, Sullivan TJ, Reese JH, Jauregui L, Miller K, Scott M, Sides GD, Shapiro R.

Am J Ther. 1995 Jul;2(7):490-498.

PMID:
11850697
15.

Dirithromycin increases ethinyl estradiol clearance without allowing ovulation.

Wermeling DP, Chandler MH, Sides GD, Collins D, Muse KN.

Obstet Gynecol. 1995 Jul;86(1):78-84.

PMID:
7784027
16.

The penetration of dirithromycin into bronchoalveolar lavage fluid and alveolar macrophages.

Baughman RP, DeSante KA, Lanier TL, Conforti PM, Sides GD.

J Antimicrob Chemother. 1994 May;33(5):1045-50. No abstract available.

PMID:
8089052
17.

Dirithromycin in the treatment of streptococcal pharyngitis.

Derriennic M, Conforti PM, Sides GD.

J Antimicrob Chemother. 1993 Mar;31 Suppl C:89-95.

PMID:
8478315
18.

Pharmacokinetics of dirithromycin.

Sides GD, Cerimele BJ, Black HR, Busch U, DeSante KA.

J Antimicrob Chemother. 1993 Mar;31 Suppl C:65-75. Review.

PMID:
8478313
19.

Safety profile of dirithromycin.

Sides GD, Conforti PM.

J Antimicrob Chemother. 1993 Mar;31 Suppl C:175-85.

PMID:
8478309
20.

Clinical efficacy of dirithromycin in acute exacerbations of chronic bronchitis.

Sides GD.

J Antimicrob Chemother. 1993 Mar;31 Suppl C:131-8.

PMID:
8478304
21.

Changes in the steady-state pharmacokinetics of theophylline during treatment with dirithromycin.

Bachmann K, Nunlee M, Martin M, Sullivan T, Jauregui L, DeSante K, Sides GD.

J Clin Pharmacol. 1990 Nov;30(11):1001-5.

PMID:
2243147
22.

New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy.

Kirst HA, Sides GD.

Antimicrob Agents Chemother. 1989 Sep;33(9):1419-22. Review.

23.

New directions for macrolide antibiotics: structural modifications and in vitro activity.

Kirst HA, Sides GD.

Antimicrob Agents Chemother. 1989 Sep;33(9):1413-8. Review. No abstract available.

24.

A comprehensive review of the clinical pharmacology and pharmacokinetics of cefaclor.

Sides GD, Franson TR, DeSante KA, Black HR.

Clin Ther. 1988;11 Suppl A:5-19. Review. No abstract available.

PMID:
3072086
25.

Transformation of energy charge and phosphofructokinase activity in alveolar macrophages.

Sides GD, Mantich NM, Boxer LA, Baehner RL.

J Reticuloendothel Soc. 1981 May;29(5):407-12. No abstract available.

PMID:
6453990

Supplemental Content

Loading ...
Support Center